Sales of Cobenfy, a groundbreaking new medication designed to stabilize the mind, reached $10 million in the last quarter of…
Trending
- Genetic breakthroughs could point pharma to a long COVID drug
- Traumatic events may predict eating disorders among Palestinians
- Police officers fire more shots than civilians in homicides, research shows
- Supreme Court upholds FDA decision banning flavored vapes
- Copycat Chick-Fil-A Sauce Recipe
- Food companies agree to phase out synthetic dyes, in win for MAHA
- Drug uptake discovery could allow IV medications to be taken orally
- Behavioral Health Is Breaking The Bank — Here’s How To Invest Wisely